Purity of transferred CD8+ T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1

Purity of transferred CD8+ T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1 Immunology and Cell Biology 94, 802 (September 2016). doi:10.1038/icb.2016.45 Authors: H Angharad Watson, Garry Dolton, Julia Ohme, Kristin Ladell, Miriam Vigar, Sophie Wehenkel, James Hindley, Rebar N Mohammed, Kelly Miners, Rhys A Luckwell, David A Price, R James Matthews & Ann Ager
Source: Immunology and Cell Biology - Category: Allergy & Immunology Authors: Source Type: research